(NO: 2009GSI18). References 1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013.

CA Cancer J Clin 2013,63(1):11–30.PubMedCrossRef 2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011,61(2):69–90.PubMedCrossRef 3. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, De Koning HJ, Auvinen A: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009,360(13):1320–1328.PubMedCrossRef 4. Stephan

C, Jung K, Lein M, Diamandis EP: PSA and other tissue kallikreins for prostate click here cancer detection. Eur J Cancer 2007,43(13):1918–1926.PubMedCrossRef p38 MAPK apoptosis 5. Eisenberger MA, Blumenstein BA, Crawford ED: Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med 1998,339(15):1036–1042.PubMedCrossRef 6. Mengus C, Le Magnen C, Trella E, Yousef K, Bubendorf L, Provenzano M, Bachmann A, Heberer M, Spagnoli GC, Wyler S: Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer. J Transl Med 2011, 9:162.PubMedCrossRef 7. Berinstein NL, Karkada M, Morse MA, Nemunaitis JJ, Chatta G, Kaufman H, Odunsi K, Nigam R, Sammatur L, MacDonald LD, Weir GM, Stanford MM, Mansour M: First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. J Transl Med 2012, 10:156.PubMedCrossRef 8. Pinto A, AZD5363 ic50 Merino M, Zamora P, Redondo A, Castelo B, Espinosa E: Targeting the endothelin axis in prostate carcinoma. Tumor Biol 2012,33(2):421–426.CrossRef 9. Huo Q, Litherland SA, Sullivan S, Hallquist H, Decker DA, Rivera-Ramirez I: Developing a nanoparticle test for prostate cancer scoring. J Transl Med Sirolimus molecular weight 2012, 10:44.PubMedCrossRef 10. Garcia-Galiano D, Navarro VM, Gaytan

F, Tena-Sempere M: Expanding roles of NUCB2/nesfatin-1 in neuroendocrine regulation. J Mol Endocrinol 2010,45(5):281–290.PubMedCrossRef 11. Miura K, Titani K, Kurosawa Y, Kanai Y: Molecular cloning of nucleobindin, a novel DNA-binding protein that contains both a signal peptide and a leucine zipper structure. Biochem Biophys Res Commun 1992,187(1):375–380.PubMedCrossRef 12. Barnikol-Watanabe S, Gross NA, Götz H, Henkel T, Karabinos A, Kratzin H, Barnikol HU, Hilschmann N: Human protein NEFA, a novel DNA binding/EF-hand/leucine zipper protein: molecular cloning and sequence analysis of the cDNA, isolation and characterization of the protein. Biol Chem Hoppe Seyler 1994,375(8):497–512.PubMedCrossRef 13.